COMMUNIQUÉS West-GlobeNewswire

Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq
19/05/2025
DURHAM, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today [...]
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025
19/05/2025
IRVINE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment [...]
Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
19/05/2025
First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient [...]
Collegium to Participate in Upcoming Investor Conferences
19/05/2025
STOUGHTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Mizuho Neuro & [...]
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
19/05/2025
- Interim Jan-2025 results from three trials of Alpha DaRT ® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate , impressive overall [...]
Mural Oncology Announces Number of Relevant Securities in Issue
19/05/2025
WALTHAM, Mass. and DUBLIN, May 19, 2025 (GLOBE NEWSWIRE) -- In accordance with Rule 2.12 of the Irish Takeover Panel Act 1997, the Irish Takeover Rules 2022 (the “ Irish Takeover Rules ”), Mural Oncology plc (Nasdaq: [...]
Eurobio Scientific: EB Development rises above 90% threshold
19/05/2025
EB Development rises above 90% threshold Paris, May 19, 2024 – 7:00 pm - Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life sciences, was informed [...]
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
19/05/2025
EB Development franchit à la hausse le seuil de 90% Paris, le 19 mai 2024 - 17h40 - Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro et les sciences [...]
IBA – ACQUISITION OF OWN SHARES
19/05/2025
Immediate Release – May 19 th , 2025 Louvain-la-Neuve, Belgium, May 19 th , 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam [...]
IBA – ACQUISITION D’ACTIONS PROPRES
19/05/2025
Publication immédiate – 19 mai 2025 Louvain-la-Neuve, Belgique, 19 mai 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam [...]
Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study
19/05/2025
- For each 5-mg/dL increase in serum TTR level within 28 days of starting treatment, the relative risk reduction of mortality was up to 31.6% through Month 30, confirming the hypothesis that ever better levels of [...]
Spineway : Combined General Meeting of June 4, 2025 - Availability of preparatory documents
19/05/2025
Press release Ecully, May 19, 2025 – 6.30 p.m. SPINEWAY Combined General Meeting of June 4, 2025 Availability of preparatory documents Spineway informs its shareholders that they are invited to attend the Combined [...]
SPINEWAY : Assemblée Générale Mixte du 4 juin 2025 - Mise à disposition des documents préparatoires
19/05/2025
Communiqué de presse Ecully, le 19 mai 2025 – 18h30 SPINEWAY Assemblée Générale Mixte du 4 juin 2025 Mise à disposition des documents préparatoires Spineway informe ses actionnaires qu’ils sont invités à participer à l’ [...]
Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo
19/05/2025
Nerandomilast, an investigational agent, met the primary endpoint of both phase III trials, FIBRONEER™-IPF and FIBRONEER™-ILD, significantly reducing the decline in forced vital capacity (FVC) [mL] by absolute change [...]
Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference
19/05/2025
KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in a newly disclosed preclinical chronic asthma model reversing disease progression KT-621 Phase 1 healthy [...]
The Coalition to Transform Clinical Trial Engagement Launches National “Champions for Change – PTO Initiative” to Expand Access to Clinical Trials for Working Patients with 7 Corporate and Non-Profit Members
19/05/2025
CHICAGO, May 19, 2025 (GLOBE NEWSWIRE) -- In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change – Paid Time Off (PTO [...]
NovelMed’s Phase II Data in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Shows Best-in-Class Efficacy as Monotherapy
19/05/2025
--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) [...]
PhotoniCare's OtoSight Demonstrates More Accurate Diagnosis and a 50 Percent Reduction in Antibiotic Usage for Pediatric Ear Infections in Large Randomized Controlled Trial
19/05/2025
DURHAM, N.C. and GRAND RAPIDS, Mich., May 19, 2025 (GLOBE NEWSWIRE) -- PhotoniCare Inc., a medical device company dedicated to delivering innovation to frontline care that demonstrably enhances patient outcomes, is [...]
The Developing Doctor Launches New Online Course to Empower Early-Career Physicians
19/05/2025
New Online Course Helps Early-Career Physicians Navigate the Critical Transition from Training to Thriving Iowa City, Iowa , May 19, 2025 (GLOBE NEWSWIRE) -- The Developing Doctor, a leader in physician coaching and [...]

Pages